{"id":641767,"date":"2024-02-07T08:46:38","date_gmt":"2024-02-07T08:46:38","guid":{"rendered":"https:\/\/www.capgemini.com\/gb-en\/?post_type=press-release&#038;p=641767"},"modified":"2025-03-10T09:03:18","modified_gmt":"2025-03-10T09:03:18","slug":"large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025","status":"publish","type":"press-release","link":"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/","title":{"rendered":"Large pharma organisations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025"},"content":{"rendered":"\t\t<div class=\"wp-block-cg-blocks-hero-press-release\">\n\t\t\t<header class=\"header-hero-press-release\" role=\"main\" id=\"main-content-press-release\">\n\t\t\t\t<div class=\"container\">\n\t\t\t\t\t<div class=\"hero-press-release\">\n\t\t\t\t\t\t<div class=\"hero-press-release-content-wrapper\">\n\t\t\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t\t<div class=\"col-12\">\n\t\t\t\t\t\t\t\t\t<div class=\"header-title\">\n\t\t\t\t\t\t\t\t\t\t<h1>\n\t\t\t\t\t\t\t\t\t\t\tLarge pharma organiSations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025\t\t\t\t\t\t\t\t\t\t<\/h1>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"header-description\">\n\t\t\t\t\t\t\t\t\t\t<p>Next-gen lab environments are now critical for innovative therapies, reduced time to market, and improved approval rates, but most are still at pilot phase<\/p>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"header-date\">\n\t\t\t\t\t\t\t\t\t\t<span>Feb 7, 2024<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"hero-press-release-downloads\">\n\t\t\t\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"col-12 col-md-6 col-lg-3\">\n\t\t\t\t\t\t\t\t\t\t\t<a class=\"download-item\" type=\"download\" href=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/02\/02_07_Lab-of-the-future_Group-news-alert.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Opens in a new window\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-icon\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-details\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-title\">Download press release<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-props\">149 KB  pdf<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"col-12 col-md-6 col-lg-3\">\n\t\t\t\t\t\t\t\t\t\t\t<a class=\"download-item\" type=\"download\" href=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/02\/Final-Infographic-Lab-of-the-Future.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Opens in a new window\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-icon\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-details\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-title\">Download infographic<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-props\">875 KB  pdf<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/header>\n\t\t<\/div>\n\t\t\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?=http:\/\/capgeminiucwe.develop\/?post_type=press-release&amp;p=179\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-tw\"><a href=\"https:\/\/twitter.com\/intent\/tweet?=http:\/\/capgeminiucwe.develop\/?post_type=press-release&amp;p=179\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-tw\"><\/i><span class=\"sr-only\">Twitter<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/shareArticle?=http:\/\/capgeminiucwe.develop\/?post_type=press-release&amp;p=179\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><div class=\"article-text article-quote-text\">\n<p><\/p>\n\n\n\n<p><strong>Paris, February 7, 2024 &#8211; Pharmaceutical organisations are rethinking their approach to the setup and operations of their labs, with a focus on accelerating digitalisation, leveraging AI, improving processes, and building the right skills and culture for a lab transformation. The need to accelerate cycle times is driving change, with the majority (92%) of pharma organisations listing this among the top drivers for future-ready \u2018next-gen\u2019 labs<a id=\"_ftnref1\" href=\"#_ftn1\"><strong>[1]<\/strong><\/a>. This is according to the Capgemini Research Institute\u2019s latest report, titled \u2018<\/strong><a href=\"https:\/\/www.capgemini.com\/gb-en\/insights\/research-library\/lab-of-the-future\/\"><strong>Building the next-gen pharma lab: Digitally connected, environmentally sustainable<\/strong><\/a><strong>\u2019, which explores the current state of pharma lab transformation, the challenges that must be overcome, and the expected benefits of building a lab of the future.<\/strong><\/p>\n\n\n\n<p><strong>Lab transformation initiatives are on the rise<\/strong><\/p>\n\n\n\n<p>According to the research, the top drivers for lab transformation are the need for faster development of innovative drugs, pressure to optimise costs, and the requirement to improve drug approval rates. As a result, pharma organisations are looking to create more agile, efficient, collaborative, and sustainable labs to help them better address these challenges and drive scientific breakthroughs.<\/p>\n\n\n\n<p>Large<a id=\"_ftnref2\" href=\"#_ftn2\">[2]<\/a> pharma organisations are planning to almost double their investment in lab transformation by 2025, to up to 7% of their revenue, up from 4% today. Nearly 75% of pharma organisations have already begun their lab modernisation journey while the rest are planning their approach.<\/p>\n\n\n\n<p><em>\u201cPharma companies today face wide-ranging, global health challenges and a cutting-edge lab environment can help them meet industry demands, making vital medicines and drugs accessible at speed. Backed by technology and continuously evolving in terms of skills, processes and infrastructure, next-gen labs are crucial to accelerate the pace of breakthrough discoveries,\u201d <\/em>said Thorsten Rall, Global Life Sciences Industry Lead at Capgemini. <em>\u201cThe opportunity for organisations lies in successfully adopting the latest technologies and developing a robust strategy, with data and AI at its core, to unlock the full potential of their lab transformation. For those looking to create and scale next-gen labs, the key remains in human-centric design, with scientists positioned at the centre of this process.\u201d<\/em><\/p>\n\n\n\n<p><strong>Most organisations are yet to advance beyond the pilot phase of lab transformation<\/strong><\/p>\n\n\n\n<p>However, while the value of a connected, cutting-edge lab environment is clear, most organisations are yet to advance beyond the pilot and proof-of-concept (PoC) phase. Only one in 10 organisations surveyed have partially or fully scaled their lab transformation initiatives.<\/p>\n\n\n\n<p>As pharma organisations strive towards more digitised and modernised labs, they face key challenges related to data and technology, processes, as well as talent. In addition, diversifying into developing new advanced and innovative therapies poses problems as processes become even more complex. According to the report, most organisations rank data-related issues (90%) and process complexity (92%) as the main challenges faced by labs.<\/p>\n\n\n\n<p>Crucially, next-gen labs require professionals with the right analytical skills to be able to derive insights from available data. But the vast majority (97%) of organisations face the challenge of hiring scientists with a mix of domain as well as digital and data expertise.<\/p>\n\n\n\n<p><strong>Leader organisations are already reaping the benefits<\/strong><\/p>\n\n\n\n<p>While many organisations are in the early stages of lab transformation, \u2018leaders\u2019<a id=\"_ftnref3\" href=\"#_ftn3\">[3]<\/a> that are spearheading these efforts are already reaping benefits at considerable scale, reporting reduced errors, higher approval rates, and optimised costs as compared to beginners<a id=\"_ftnref4\" href=\"#_ftn4\">[4]<\/a>. Additionally, half of leaders have achieved accelerated time to market through lab transformation measures compared to 23% of beginners.<\/p>\n\n\n\n<p>Leaders are also realising sustainability-related benefits, with nearly 36% of these organisations witnessing a reduction in carbon footprint due to lab modernisation initiatives, as compared to only 18% of beginners.&nbsp;<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><a href=\"#_ftnref1\" id=\"_ftn1\">[1]<\/a> &nbsp;Next-gen labs are labs which continuously evolve their technology, infrastructure, ways of working, skills, and culture.<\/p>\n\n\n\n<p><a id=\"_ftn2\" href=\"#_ftnref2\">[2]<\/a> Large pharma organisations are defined as those with $10 billion or more in annual revenue.<\/p>\n\n\n\n<p><a id=\"_ftn3\" href=\"#_ftnref3\">[3]<\/a> Leaders are those organisations that are strong on both \u201cfoundations\u201d (such as tools, technologies, data, architecture, and connectivity) and \u201cenablers\u201d (such as vision, strategy, people, processes, culture, and skills) of lab transformation.<\/p>\n\n\n\n<p><a id=\"_ftn4\" href=\"#_ftnref4\">[4]<\/a> Beginners are those organisations that fall behind on both \u201cfoundations\u201d and \u201cenablers\u201d of lab transformation<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n<div class=\"wp-block-cg-blocks-cg-block-related-content\"><section class=\"relatedContentBlock\"><div class=\"container\"><div class=\"row\"><div class=\"content-title col-12 col-md-8\"><h2 class=\"related-content-heading\">Related news<\/h2><\/div><\/div><div class=\"row relatedContent\"><div class=\"col-lg-4 col-md-6 col-xs-12\">\n\t\t\t\t\t\t\t<div class=\"box\">\n\t\t\t\t\t\t\t\t<a aria-label=\"Read more about Global millionaire population jumps by nearly 2 million in 2025, driven by strong stock market performance worldwide\" href=\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/global-millionaire-population-jumps-by-nearly-2-million-in-2025-driven-by-strong-stock-market-performance-worldwide\/\" class=\"anchorWrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"box-tag\"><span>Reports<\/span><\/span>\n\t\t\t\t\t\t\t\t\t<div class=\"box-title\"><h3 class=\"box-subtitle\">Global millionaire population jumps by nearly 2 million in 2025, driven by strong stock market performance worldwide<\/h3><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-date\">\n\t\t\t\t\t\t\t\t\t\t<span>Jun 4, 2026<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-bottom\">\n\t\t\t\t\t\t\t\t\t\t&lt;a class=&quot;link-download&quot; href=&quot;https:\/\/www.capgemini.com\/wp-content\/uploads\/2026\/06\/06_04_Capgemini-Press-release_World-Wealth-Report-2026.pdf&quot; aria-label=&quot;Download Press Release&quot; target=&quot;_blank&quot;  type=&quot;download&quot; title=&quot;Opens in a new window&quot;&gt;\n\t\t\t\t\t\t\t&lt;span&gt;Download press release&lt;\/span&gt;\n\t\t\t\t\t\t\t&lt;span&gt;160 KB PDF&lt;\/span&gt;\n\t\t\t\t\t\t&lt;\/a&gt;\n\t\t\t\t\t\t\t\t\t\t<a class=\"more\" aria-label=\"Read more about Global millionaire population jumps by nearly 2 million in 2025, driven by strong stock market performance worldwide\" href=\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/global-millionaire-population-jumps-by-nearly-2-million-in-2025-driven-by-strong-stock-market-performance-worldwide\/\">Read more about<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div><div class=\"col-lg-4 col-md-6 col-xs-12\">\n\t\t\t\t\t\t\t<div class=\"box\">\n\t\t\t\t\t\t\t\t<a aria-label=\"Read more about The moment of AI truth for property &#038; casualty insurance: trailblazers see 21% higher revenue growth while broader industry lags\" href=\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/the-moment-of-ai-truth-for-property-casualty-insurance-trailblazers-see-21-higher-revenue-growth-while-broader-industry-lags\/\" class=\"anchorWrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"box-tag\"><span>Reports<\/span><\/span>\n\t\t\t\t\t\t\t\t\t<div class=\"box-title\"><h3 class=\"box-subtitle\">The moment of AI truth for property &#038; casualty insurance: trailblazers see 21% higher revenue growth while broader industry lags<\/h3><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-date\">\n\t\t\t\t\t\t\t\t\t\t<span>May 5, 2026<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-bottom\">\n\t\t\t\t\t\t\t\t\t\t&lt;a class=&quot;link-download&quot; href=&quot;https:\/\/www.capgemini.com\/wp-content\/uploads\/2026\/05\/2026_05_05_Capgemini-Press-Release_WPCIR.pdf&quot; aria-label=&quot;Download Press Release&quot; target=&quot;_blank&quot;  type=&quot;download&quot; title=&quot;Opens in a new window&quot;&gt;\n\t\t\t\t\t\t\t&lt;span&gt;Download press release&lt;\/span&gt;\n\t\t\t\t\t\t\t&lt;span&gt;175 KB PDF&lt;\/span&gt;\n\t\t\t\t\t\t&lt;\/a&gt;\n\t\t\t\t\t\t\t\t\t\t<a class=\"more\" aria-label=\"Read more about The moment of AI truth for property &#038; casualty insurance: trailblazers see 21% higher revenue growth while broader industry lags\" href=\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/the-moment-of-ai-truth-for-property-casualty-insurance-trailblazers-see-21-higher-revenue-growth-while-broader-industry-lags\/\">Read more about<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div><div class=\"col-lg-4 col-md-6 col-xs-12\">\n\t\t\t\t\t\t\t<div class=\"box\">\n\t\t\t\t\t\t\t\t<a aria-label=\"Read more about Reindustrialisation moves into a more selective, strategic phase in Europe and the US\" href=\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/reindustrialisation-moves-into-a-more-selective-strategic-phase-in-europe-and-the-us\/\" class=\"anchorWrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"box-tag\"><span>Reports<\/span><\/span>\n\t\t\t\t\t\t\t\t\t<div class=\"box-title\"><h3 class=\"box-subtitle\">Reindustrialisation moves into a more selective, strategic phase in Europe and the US<\/h3><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-date\">\n\t\t\t\t\t\t\t\t\t\t<span>Apr 20, 2026<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-bottom\">\n\t\t\t\t\t\t\t\t\t\t&lt;a class=&quot;link-download&quot; href=&quot;https:\/\/www.capgemini.com\/wp-content\/uploads\/2026\/04\/2026_04_20_Capgemini_Reindustrialization-of-Europe-and-the-US-report_3e-edition_press-release.pdf&quot; aria-label=&quot;Download Press Release&quot; target=&quot;_blank&quot;  type=&quot;download&quot; title=&quot;Opens in a new window&quot;&gt;\n\t\t\t\t\t\t\t&lt;span&gt;Download press release&lt;\/span&gt;\n\t\t\t\t\t\t\t&lt;span&gt;152 KB PDF&lt;\/span&gt;\n\t\t\t\t\t\t&lt;\/a&gt;\n\t\t\t\t\t\t\t\t\t\t<a class=\"more\" aria-label=\"Read more about Reindustrialisation moves into a more selective, strategic phase in Europe and the US\" href=\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/reindustrialisation-moves-into-a-more-selective-strategic-phase-in-europe-and-the-us\/\">Read more about<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div><\/div><\/div><\/section><\/div>","protected":false},"excerpt":{"rendered":"<p>Pharmaceutical organisations are rethinking their approach to the setup and operations of their labs, with a focus on accelerating digitalisation, leveraging AI, improving processes, and building the right skills and culture for a lab transformation. The need to accelerate cycle times is driving change, with the majority (92%) of pharma organisations listing this among the top drivers for future-ready \u2018next-gen\u2019 labs. This is according to the Capgemini Research Institute\u2019s latest report, titled \u2018Building the next-gen pharma lab: Digitally connected, environmentally sustainable\u2019, which explores the current state of pharma lab transformation, the challenges that must be overcome, and the expected benefits of building a lab of the future.<\/p>\n","protected":false},"author":387,"featured_media":0,"template":"","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"0cef272c-85c5-43a3-b16c-5ddf5bcdd838\",\"blogId\":\"\",\"domain\":\"\",\"sitePath\":\"\",\"postLink\":\"\",\"postId\":null,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":true,"cg_dt_link_disabled":false,"footnotes":"","related_resource_url":"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/02\/02_07_Lab-of-the-future_Group-news-alert.pdf","related_resource_id":990351,"related_resource_size":"149 KB","related_resource_type":"pdf","cg_author":0,"featured_focal_points":""},"tags":[],"press-release-type":[87],"brand":[],"class_list":["post-641767","press-release","type-press-release","status-publish","hentry","press-release-type-reports"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Large pharma organisations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025 - Capgemini UK<\/title>\n<meta name=\"description\" content=\"Next-gen lab environments are now critical for innovative therapies, reduced time to market, and improved approval rates, but most are still at pilot phase\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Large pharma organisations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025\" \/>\n<meta property=\"og:description\" content=\"Next-gen lab environments are now critical for innovative therapies, reduced time to market, and improved approval rates, but most are still at pilot phase\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini UK\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-10T09:03:18+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/\",\"url\":\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/\",\"name\":\"Large pharma organisations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025 - Capgemini UK\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/gb-en\/#website\"},\"datePublished\":\"2024-02-07T08:46:38+00:00\",\"dateModified\":\"2025-03-10T09:03:18+00:00\",\"description\":\"Next-gen lab environments are now critical for innovative therapies, reduced time to market, and improved approval rates, but most are still at pilot phase\",\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/gb-en\/#website\",\"url\":\"https:\/\/www.capgemini.com\/gb-en\/\",\"name\":\"Capgemini UK\",\"description\":\"Get the future you want\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/gb-en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Large pharma organisations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025 - Capgemini UK","description":"Next-gen lab environments are now critical for innovative therapies, reduced time to market, and improved approval rates, but most are still at pilot phase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/","og_locale":"en_GB","og_type":"article","og_title":"Large pharma organisations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025","og_description":"Next-gen lab environments are now critical for innovative therapies, reduced time to market, and improved approval rates, but most are still at pilot phase","og_url":"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/","og_site_name":"Capgemini UK","article_modified_time":"2025-03-10T09:03:18+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/","url":"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/","name":"Large pharma organisations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025 - Capgemini UK","isPartOf":{"@id":"https:\/\/www.capgemini.com\/gb-en\/#website"},"datePublished":"2024-02-07T08:46:38+00:00","dateModified":"2025-03-10T09:03:18+00:00","description":"Next-gen lab environments are now critical for innovative therapies, reduced time to market, and improved approval rates, but most are still at pilot phase","inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/gb-en\/#website","url":"https:\/\/www.capgemini.com\/gb-en\/","name":"Capgemini UK","description":"Get the future you want","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/gb-en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"}]}},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Large pharma organisations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025","url":"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/"},"thumbnailUrl":"","image":{"@type":"ImageObject","url":""},"articleSection":"Uncategorized","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini UK","logo":""},"keywords":[],"dateCreated":"2024-02-07T08:46:38Z","datePublished":"2024-02-07T08:46:38Z","dateModified":"2025-03-10T09:03:18Z"},"rendered":"<meta name=\"parsely-title\" content=\"Large pharma organisations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/gb-en\/news\/press-releases\/large-pharma-organisations-to-invest-nearly-7-of-revenue-on-building-connected-cutting-edge-lab-environments-by-2025\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-pub-date\" content=\"2024-02-07T08:46:38Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/gb-en\/wp-content\/themes\/capgemini2025\/assets\/images\/mockup.png","featured_image_alt":false,"jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini UK","distributor_original_site_url":"https:\/\/www.capgemini.com\/gb-en","push-errors":false,"tag_names":[],"_links":{"self":[{"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/press-release\/641767","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/types\/press-release"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/users\/387"}],"version-history":[{"count":5,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/press-release\/641767\/revisions"}],"predecessor-version":[{"id":682444,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/press-release\/641767\/revisions\/682444"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/media?parent=641767"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/tags?post=641767"},{"taxonomy":"press-release-type","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/press-release-type?post=641767"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/brand?post=641767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}